肝动脉灌注化疗在伴有肝转移的恶性肿瘤中的现代展望。
Modern prospection for hepatic arterial infusion chemotherapy in malignancies with liver metastases.
作者信息
Liang Yi-Hsin, Shao Yu-Yun, Chen Jia-Yi, Liang Po-Chin, Cheng Ann-Lii, Lin Zhong-Zhe
机构信息
Department of Hemato-Oncology, E-Da Hospital, No. 1, Yi-da Road, Jiaosu Village, Yanchao, Kaohsiung 82445, Taiwan ; Department of Oncology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei City 10002, Taiwan.
出版信息
Int J Hepatol. 2013;2013:141590. doi: 10.1155/2013/141590. Epub 2013 Apr 17.
Abstract
Malignancy with liver metastasis plays an important role in daily oncology practice, especially for primary cancers of the gastrointestinal tract and hepatopancreatobiliary system. On account of the dual vascular supply system and the fact that most metastatic liver tumors are supplied by the hepatic artery, hepatic artery infusion chemotherapy (HAIC) is an appealing method for the treatment of liver metastases. Herein, we summarize recent study results reported in the literature regarding the use of HAIC for metastatic liver tumors, with special focus on colorectal cancer.
摘要
伴有肝转移的恶性肿瘤在日常肿瘤学实践中起着重要作用，尤其是对于胃肠道和肝胆胰系统的原发性癌症。由于双重血管供应系统以及大多数转移性肝肿瘤由肝动脉供血这一事实，肝动脉灌注化疗（HAIC）是治疗肝转移瘤的一种有吸引力的方法。在此，我们总结了文献中报道的关于使用HAIC治疗转移性肝肿瘤的最新研究结果，特别关注结直肠癌。
相似文献
1
Modern prospection for hepatic arterial infusion chemotherapy in malignancies with liver metastases.
Int J Hepatol. 2013;2013:141590. doi: 10.1155/2013/141590. Epub 2013 Apr 17.
2
[Hepatic arterial infusion chemotherapy for liver metastases from colorectal cancer].
Gan To Kagaku Ryoho. 2000 Dec;27(14):2193-200.
3
Role of Hepatic Artery Infusion Chemotherapy in Treatment of Initially Unresectable Colorectal Liver Metastases: A Review.
JAMA Surg. 2019 Aug 1;154(8):768-776. doi: 10.1001/jamasurg.2019.1694.
4
Adjuvant hepatic arterial infusion chemotherapy after curative resection for Dukes C colorectal cancer: a pilot study.
Hepatogastroenterology. 2004 Jan-Feb;51(55):124-7.
5
Hepatic artery infusion therapy is effective for chemotherapy-resistant liver metastatic colorectal cancer.
World J Surg Oncol. 2015 Oct 9;13:296. doi: 10.1186/s12957-015-0704-5.
6
Hepatic arterial infusion chemotherapy through a port-catheter system as preoperative initial therapy in patients with advanced liver dysfunction due to synchronous and unresectable liver metastases from colorectal cancer.
Cardiovasc Intervent Radiol. 2008 Jan-Feb;31(1):86-90. doi: 10.1007/s00270-007-9189-0. Epub 2007 Oct 10.
7
[Study of hepatic arterial infusion chemotherapy for prophylaxis of liver metastases of colorectal cancer after hepatic resection].
Gan To Kagaku Ryoho. 1995 Sep;22(11):1497-9.
8
Postoperative prophylactic hepatic arterial infusion chemotherapy for stage III colorectal cancer: a retrospective study.
Onco Targets Ther. 2016 Sep 26;9:5897-5902. doi: 10.2147/OTT.S116815. eCollection 2016.
9
Hepatic Arterial Infusion Chemotherapy of 5-Fluorouracil for Patients with Unresectable Liver Metastases from Colorectal Cancer Refractory to Standard Systemic Chemotherapy: A Multicenter Retrospective Study.
Oncology. 2020;98(5):267-272. doi: 10.1159/000505520. Epub 2020 Feb 24.
10
Hepatic Arterial Infusion Chemotherapy for Life Threatening Patients due to Liver Metastases from Colorectal Cancer with Cetuximab.
Hepatogastroenterology. 2015 May;62(139):612-4.
引用本文的文献
1
Sorafenib Plus Hepatic Arterial Infusion Chemotherapy in Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Turk J Gastroenterol. 2023 Apr;34(4):311-321. doi: 10.5152/tjg.2023.22383.
2
Dichloroacetate enhances the antitumor effect of pirarubicin via regulating the ROS-JNK signaling pathway in liver cancer cells.
Cancer Drug Resist. 2020 Sep 4;3(4):947-958. doi: 10.20517/cdr.2020.32. eCollection 2020.
3
Effects of hepatic arterial infusion chemotherapy in the treatment of hepatocellular carcinoma: A meta-analysis.
Medicine (Baltimore). 2020 Jun 26;99(26):e20745. doi: 10.1097/MD.0000000000020745.
4
A systematic review and meta-analysis to reappraise the role of adjuvant hepatic arterial infusion for colorectal cancer liver metastases.
Int J Colorectal Dis. 2015 Aug;30(8):1091-102. doi: 10.1007/s00384-015-2246-2. Epub 2015 May 27.
本文引用的文献
1
What is the potential role of hepatic arterial infusion chemo-therapy in the current armamentorium against colorectal cancer.
J Gastrointest Oncol. 2012 Jun;3(2):130-8. doi: 10.3978/j.issn.2078-6891.2011.025.
2
Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study.
J Clin Oncol. 2012 May 20;30(15):1755-62. doi: 10.1200/JCO.2011.38.0915. Epub 2012 Apr 2.
3
Safety and optimal management of hepatic arterial infusion chemotherapy after pancreatectomy for pancreatobiliary cancer.
AJR Am J Roentgenol. 2012 Apr;198(4):923-30. doi: 10.2214/AJR.11.6751.
4
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.
Lancet. 2011 Jun 18;377(9783):2103-14. doi: 10.1016/S0140-6736(11)60613-2. Epub 2011 Jun 5.
5
Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status.
J Clin Oncol. 2011 May 20;29(15):2011-9. doi: 10.1200/JCO.2010.33.5091. Epub 2011 Apr 18.
6
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
7
Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study.
Ann Oncol. 2011 Jul;22(7):1535-1546. doi: 10.1093/annonc/mdq632. Epub 2011 Jan 12.
8
Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer.
J Clin Oncol. 2011 Mar 1;29(7):884-9. doi: 10.1200/JCO.2010.32.5977. Epub 2010 Dec 28.
9
Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival.
Ann Surg Oncol. 2011 Feb;18(2):431-8. doi: 10.1245/s10434-010-1333-4. Epub 2010 Sep 16.
10
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Lancet. 2010 Aug 28;376(9742):687-97. doi: 10.1016/S0140-6736(10)61121-X. Epub 2010 Aug 19.
Zotero 插件